Name | Bopindolol fumarate |
---|
Description | Bopindolol ((±)-Bopindolol) fumarate is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol fumarate is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol fumarate is a prodrug of pindolol and can be used for essential and renovascular hypertension research[1][2]. |
---|---|
Related Catalog | |
Target |
β1 adrenoceptor β2 adrenoceptor β3 adrenoceptor |
In Vivo | Bopindolol (intravenous injection; l8, 16 and 32 μg/kg) fumarate causes a dose-dependent inhibition of isoprenaline-induced tachycardia, and this agent is 4 times more potent than propranolol in anaesthetised dogs[1]. Bopindolol (intraperitoneal injection; 3.0 mg/kg) fumarate reduces the diastolic blood pressure (DBP) in pithed rats. And pindolol (1.0 mg/kg) produces similar decreases in DBP of about 8 mmHg. it also produces a dose-dependent decrease in heart rate[2]. |
References |
Molecular Formula | C27H32N2O7 |
---|---|
Molecular Weight | 496.55 |